These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22774602)

  • 1. [Expressions of E-cadherin and alpha-catenin in benign, malignant and metastatic prostate tumors].
    Jiang T; Jiang H; Su XM; Zheng L; Li QL; Zhang ZW; Li XC
    Zhonghua Nan Ke Xue; 2012 Jun; 18(6):499-503. PubMed ID: 22774602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of E-cadherin and N-cadherin in prostate cancer and their implications].
    Liu Y; Chen XG; Liang CZ
    Zhonghua Nan Ke Xue; 2014 Sep; 20(9):781-6. PubMed ID: 25306803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vinculin and the androgen receptor in prostate cancer: expressions and correlations].
    Zhu LY; Zhong KB; Lu SX; He LY
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):794-8. PubMed ID: 21171262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
    Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
    Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [P53 expression and its clinical significance in prostatic carcinoma].
    Jiang T; Jiang H; Song XS; Li XC; Li QL
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):448-51, 454. PubMed ID: 15999492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of PIM-1 in prostate cancer tissue and its relationship with PSA recurrence].
    Zhang CT; Xu Y; Luo F; Zhang ZH; Liu RL; Yang K; Ma BJ
    Zhonghua Nan Ke Xue; 2012 Apr; 18(4):323-6. PubMed ID: 22574367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of ERK and p-ERK in advanced prostate cancer].
    Han J; Zhang P; Zheng L; Zhang Y; Wang KN; Fan LM; Xie HD; Wang SR; Zhang ZW; Wang QF; Jiang T
    Zhonghua Nan Ke Xue; 2017 May; 23(5):406-411. PubMed ID: 29717829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential immunohistochemical expression of CD44s, E-cadherin and β-catenin among hyperplastic and neoplastic lesions of the prostate gland.
    Lazari P; Poulias H; Gakiopoulou H; Thomopoulou GH; Barbatis C; Lazaris AC
    Urol Int; 2013; 90(1):109-16. PubMed ID: 23220849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.
    Horvath LG; Henshall SM; Lee CS; Kench JG; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
    Int J Cancer; 2005 Jan; 113(3):415-22. PubMed ID: 15455387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expressions of Bcl-xl and caspase-3 in the prostate cancer tissue and their correlation].
    Zhonghua Nan Ke Xue; 2016 Apr; 22(4):306-10. PubMed ID: 30088397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of VEGF in prostate cancer and its correlation with ET-1].
    Zhou WQ; Yin HL; Zhang ZY; Yi XM; Ge JP; Zhou SG; Cheng W; Wei W; Ma HQ; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2008 Nov; 14(11):987-92. PubMed ID: 19102498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of FOXA1 with the malignancy and progression of prostate cancer].
    Feng W; Zhang HB; Wang YM; Hu JL
    Zhonghua Nan Ke Xue; 2015 May; 21(5):414-9. PubMed ID: 26117938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EZH2 expression in human prostate cancer and its clinicopathologic significance].
    Li J; Fan QH; Fan XS; Zhou W; Qiu Y; Qiu L
    Zhonghua Nan Ke Xue; 2010 Feb; 16(2):123-8. PubMed ID: 20369694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of UPR Signaling Pathway is Associated With the Malignant Progression and Poor Prognosis in Prostate Cancer.
    Liu J; Xiao M; Li J; Wang D; He Y; He J; Gao F; Mai L; Li Y; Liang Y; Liu Y; Zhong X
    Prostate; 2017 Feb; 77(3):274-281. PubMed ID: 27718273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
    Hasby EA; Saied EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of serum β2-microglobulin levels with prostate-specific antigen, Gleason score, clinical stage, tumor metastasis and therapy efficacy in prostate cancer.
    Zhang YX; Wang L; Ji PY; Zhao GG; Zhong GP; Wang ZP
    Arch Med Res; 2013 May; 44(4):259-65. PubMed ID: 23707648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
    Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
    Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.